Hybrid disease prediction approach leveraging digital twin and metaverse technologies for health consumer
BMC Medical Informatics and Decision Making · 2024
DOI: 10.1186/s12911-024-02495-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Medical Informatics and Decision Making, 2024. Verfasst von Chaitanya Kulkarni und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Engineering, Vidya Pratishthan's Kamalnayan Bajaj Institute of Engineering and Technology, Baramati, Pune, 413133, Maharashtra…. Hauptthemen laut MEDLINE: Technology, Big Data. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Emerging from the convergence of digital twin technology and the metaverse, consumer health (MCH) is witnessing a transformative shift. The amalgamation of bioinformatics with healthcare Big Data has ushered in a new era of disease prediction models that harness comprehensive medical data, enabling the anticipation of illnesses even before the onset of symptoms. In this model, deep neural networks stand out because they improve accuracy remarkably by increasing network depth and making weight changes using gradient descent. Nonetheless, traditional methods face their own set of challenges, including the issues of gradient instability and slow training. In this case, the Broad Learning System (BLS) stands out as a good alternative. It gets around the problems with gradient descent and lets you quickly rebuild a model through incremental learning. One problem with BLS is that it has trouble extracting complex features from complex medical data. This makes it less useful in a wide range of healthcare situations. In response to these challenges, we introduce DAE-BLS, a novel hybrid model that marries Denoising AutoEncoder (DAE) noise reduction with the efficiency of BLS. This hybrid approach excels in robust feature extraction, particularly within the intricate and multifaceted world of medical data. Validation using diverse datasets yields impressive results, with accuracies reaching as high as 98.50%. DAE-BLS’s ability to rapidly adapt through incremental learning holds great promise for accurate and agile disease prediction, especially within the complex and dynamic healthcare scenarios of today.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Computer Engineering, Vidya Pratishthan's Kamalnayan Bajaj Institute of Engineering and Technology, Baramati, Pune, 413133, Maharashtra, India.
- M.D. Research, Intervention Treatment Institute, Houston, TX, USA.
- Software Engineer, Alphabet Life Science, Dallas, TX, 75063, USA.
- Model Institute of Engineering and Technology, Jammu, J&K, India. bhatsab4@gmail.com.
- Department of Computer Science and Mathematics, Lebanese American University, Beirut, Lebanon.
- Symbiosis Law School (SLS), Symbiosis International (Deemed University) (SIU), Vimannagar, Pune, Maharashtra, India.
Zitieren
APA
Kulkarni, C., Quraishi, A., Raparthi, M., Shabaz, M., Khan, M. A., Varma, R. A., Keshta, I., Soni, M., & Byeon, H. (2024). Hybrid disease prediction approach leveraging digital twin and metaverse technologies for health consumer. BMC Medical Informatics and Decision Making. https://doi.org/10.1186/s12911-024-02495-2
Vancouver
Kulkarni C, Quraishi A, Raparthi M, Shabaz M, Khan MA, Varma RA, et al. Hybrid disease prediction approach leveraging digital twin and metaverse technologies for health consumer. BMC Medical Informatics and Decision Making. 2024. doi:10.1186/s12911-024-02495-2
BibTeX
@article{Kulkarni2024,
author = {Kulkarni, Chaitanya and Quraishi, Aadam and Raparthi, Mohan and Shabaz, Mohammad and Khan, Muhammad Attique and Varma, Raj A and Keshta, Ismail and Soni, Mukesh and Byeon, Haewon},
title = {Hybrid disease prediction approach leveraging digital twin and metaverse technologies for health consumer},
journal = {BMC Medical Informatics and Decision Making},
year = {2024},
doi = {10.1186/s12911-024-02495-2}
}
EUVIMED